Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Treasury Shares: 2020-2025

Historic Treasury Shares for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Sep 2025 value amounting to $353,743.

  • Mirum Pharmaceuticals' Treasury Shares rose 24.14% to $353,743 in Q3 2025 from the same period last year, while for Sep 2025 it was $353,743, marking a year-over-year increase of 24.14%. This contributed to the annual value of $284,955 for FY2024, which is 92.75% up from last year.
  • According to the latest figures from Q3 2025, Mirum Pharmaceuticals' Treasury Shares is $353,743, which was down 0.00% from $353,743 recorded in Q2 2025.
  • In the past 5 years, Mirum Pharmaceuticals' Treasury Shares ranged from a high of $353,743 in Q1 2025 and a low of $22,270 during Q3 2022.
  • For the 3-year period, Mirum Pharmaceuticals' Treasury Shares averaged around $278,852, with its median value being $294,770 (2024).
  • In the last 5 years, Mirum Pharmaceuticals' Treasury Shares plummeted by 85.71% in 2022 and then surged by 120.92% in 2024.
  • Mirum Pharmaceuticals' Treasury Shares (Quarterly) stood at $122,464 in 2021, then plummeted by 85.71% to $22,270 in 2022, then skyrocketed by 52.51% to $147,835 in 2023, then skyrocketed by 92.75% to $284,955 in 2024, then climbed by 24.14% to $353,743 in 2025.
  • Its last three reported values are $353,743 in Q3 2025, $353,743 for Q2 2025, and $353,743 during Q1 2025.